FDA Warns Campbell on Soup Procedures

U.S. regulators have warned a division of Campbell Soup Co. that its refrigerated clam chowder soup was prepared in unsanitary conditions that could pose a risk to consumers, the Food and Drug Administration said.

The warning letter was sent to the Campbell unit Dec. 22 but posted Tuesday on the FDA’s website.

It requires Campbell’s StockPot unit to implement safety and testing standards to ensure that the refrigerated, ready-to-use clam chowder soup is safe.

The FDA said a September inspection of the StockPot plant in Woodinville, Wash., turned up “serious deviations” from seafood safety regulations.

Campbell executives were not immediately available to comment.